Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence
- 24 July 2008
- journal article
- review article
- Published by Springer Nature in Brain Structure and Function
- Vol. 213 (1-2) , 43-61
- https://doi.org/10.1007/s00429-008-0191-3
Abstract
Studies reviewed here implicate the extended amygdala in the negative affective states and increased drug-seeking that occur during protracted abstinence from chronic drug exposure. Norepinephrine (NE) and corticotropin-releasing factor (CRF) signaling in the extended amygdala, including the bed nucleus of the stria terminalis, shell of the nucleus accumbens, and central nucleus of the amygdala, are generally involved in behavioral responses to environmental and internal stressors. Hyperactivity of stress response systems during addiction drives many negative components of drug abstinence. In particular, NE signaling from the nucleus tractus solitarius (NTS) to the extended amygdala, along with increased CRF transmission within the extended amygdala, are critical for the aversiveness of acute opiate withdrawal as well as stress-induced relapse of drug-seeking for opiates, cocaine, ethanol, and nicotine. NE and CRF transmission in the extended amygdala are also implicated in the increased anxiety that occurs during prolonged abstinence from chronic opiates, cocaine, ethanol, and cannabinoids. Many of these stress-associated behaviors are reversed by NE or CRF antagonists given systemically or locally within the extended amygdala. Finally, increased Fos activation in the extended amygdala and NTS is associated with the enhanced preference for drugs and decreased preference for natural rewards observed during protracted abstinence from opiates and cocaine, indicating that these areas are involved in the altered reward processing associated with addiction. Together, these findings suggest that involvement of the extended amygdala and its noradrenergic afferents in anxiety, stress-induced relapse, and altered reward processing reflects a common function for these circuits in stress modulation of drug-seeking.Keywords
This publication has 209 references indexed in Scilit:
- The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systemsEuropean Journal of Pharmacology, 2008
- CRF1 receptor antagonists attenuate escalated cocaine self-administration in ratsPsychopharmacology, 2007
- Effects of the CRF receptor antagonist d-Phe CRF(12–41) and the α2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in ratsNeuropharmacology, 2007
- Elevations of FosB in the nucleus accumbens during forced cocaine abstinence correlate with divergent changes in reward functionNeuroscience, 2007
- Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockoutPharmacology Biochemistry and Behavior, 2007
- Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent RatsBiological Psychiatry, 2007
- Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawalBehavioural Brain Research, 2006
- Role of corticotropin releasing factor in anxiety disorders: A translational research perspectiveHormones and Behavior, 2006
- Acute morphine induces oscillatory discharge of noradrenergic locus coeruleus neurons in the waking monkeyNeuroscience Letters, 1992
- Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidineLife Sciences, 1984